11C-Choline-PET/MR and 11C-Choline PET/CT

“Initial experience in restaging of patients with recurrent prostate cancer: Comparison of 11C-Choline-PET/MR and 11C-Choline-PET/CT,”- Abstract
SNMMI’s 60th Annual Meeting, June 8–12, 2013, Vancouver, British Columbia.

This entry was posted in Treatments for Prostate Cancer and tagged , , , . Bookmark the permalink.

2 Responses to 11C-Choline-PET/MR and 11C-Choline PET/CT

  1. C11 choline was only approved by the FDA for use at Mayo in Rochester. Where was this study done that compares C11 MRI versus PET scans? Thanks. Also, is the full study you referenced available online?

  2. This study was done at the Technical University Munich in Germany. It may be cost prohibitive from a practical standpoint: “Nevertheless, the expense of PET/MR demands a high bar for clinical utility. “It has to be looked at on a more global population scale to see whether the overall benefit is worthwhile for medical centers to adopt that technology,” said Dr. Kwee. He noted that most major medical centers have both PET and MRI scanners, and doing consecutive scans can often provide the same information, albeit with potential imaging artifacts because of position changes between scans.”